Managing Myeloma

March Poll

How long do you typically treat myeloma patients with bisphosphonates?

6 months
12 months
2 years
Indefinitely

In instances of renal insufficiency (CrCl 30–60 ml/min), but presence of hypercalcemia or severe lytic bone disease, I typically:

Use pamidronate as directed
Use zoledronic acid as directed, reduce the dose for renal impairment
Use zoledronic acid without dose adjustment but >15-minute infusion

Do you question your patients using bisphosphonates about any planned dental work and dental history?

At every regularly scheduled visit
At the beginning of treatment
I don’t ask but instruct patients to inform me of any planned dental work
I don’t ask patients about planned dental work or dental history

In instances of osteonecrosis of the jaw (ONJ), I usually:

Discontinue bisphosphonate use for 3 months
Discontinue bisphosphonate use for 6 months
Discontinue bisphosphonate use for 1 year
Discontinue bisphosphonate use indefinitely

Do you see a potential role for denosumab for the treatment of bone disease in myeloma patients?

Yes
No

What's New

Fan us on Facebook
Nurse Focus - What changes should we expect to see in the multiple myeloma landscape?
by Carol S. Viele, RN, MS, CNS
What’s new in the management of vertebral compression fractures?
by James R. Berenson, MD
Can we minimize the risk of osteonecrosis of the jaw?
by Ann F. Mohrbacher, MD
Nurse Focus - Implications of Cytogenetics in the Prognosis and Treatment of MM
by Sandra E. Kurtin, RN, MS, AOCN, ANP-C
Unifying Practice Patterns Among Academic and Community Clinicians: Focus on Myeloma Web Simulcast
Audio/Video Programs
Accredited Newsletter Series
Calendar

Last Updated ( Tuesday, 09 March 2010 22:11 )

Point of Care CME

Physicians, earn CME credits while searching for answers to questions about your patients. Click here to start your search or press the search button above.

Last Updated ( Saturday, 14 November 2009 00:42 )

Managing Myeloma

March Poll

What's New

Point of Care CME

Your Opinion Matters

In the News


	CNE Programs FAQ Library Clinical Commentaries Nurse Forum


How frequently do you receive referrals from an orthopedic specialist or see multiple myeloma patients who have visited an orthopedic specialist prior to their initial consult with you? Majority of the time (>75%) Very frequently (>50%-74%) Frequently (25%-50%) Not often (<25%)